Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Meyer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|January 12, 1996
Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosisY R Chen, C F Meyer, T H Tan
The Journal of Biological Chemistry|April 12, 1996
Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activationC F Meyer, X Wang, C Chang, et al.
Oncogene|December 22, 1999
Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1)Y R Chen, C F Meyer, B Ahmed, et al.
Genes & Development|September 15, 1996
Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascadeM C Hu, W R Qiu, X Wang, et al.
Oncogene|October 19, 1999
Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinaseM C Hu, Y p Wang, W R Qiu, et al.
Molecular and Cellular Biology|January 16, 1999
Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinaseP Ling, Z Yao, C F Meyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinaseK Diener, X S Wang, C Chen, et al.
The Journal of Biological Chemistry|March 30, 2001
Involvement of hematopoietic progenitor kinase 1 in T cell receptor signalingP Ling, C F Meyer, L P Redmond, et al.
International Journal of Cancer|February 6, 2013
A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomaK A Thornton, A R Chen, M M Trucco, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|January 12, 1996
Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosisY R Chen, C F Meyer, T H Tan
The Journal of Biological Chemistry|April 12, 1996
Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activationC F Meyer, X Wang, C Chang, et al.
Oncogene|December 22, 1999
Caspase-mediated cleavage and functional changes of hematopoietic progenitor kinase 1 (HPK1)Y R Chen, C F Meyer, B Ahmed, et al.
Genes & Development|September 15, 1996
Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascadeM C Hu, W R Qiu, X Wang, et al.
Oncogene|October 19, 1999
Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinaseM C Hu, Y p Wang, W R Qiu, et al.
Molecular and Cellular Biology|January 16, 1999
Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinaseP Ling, Z Yao, C F Meyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
Activation of the c-Jun N-terminal kinase pathway by a novel protein kinase related to human germinal center kinaseK Diener, X S Wang, C Chen, et al.
The Journal of Biological Chemistry|March 30, 2001
Involvement of hematopoietic progenitor kinase 1 in T cell receptor signalingP Ling, C F Meyer, L P Redmond, et al.
International Journal of Cancer|February 6, 2013
A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomaK A Thornton, A R Chen, M M Trucco, et al.
Pageof 1